Heron Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Heron Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $127,044,000. The net income raised on -$110,559,000 and profit margin reached -87%. Total operating expenses were $172,554,000.
Profit Margin
| 2014 | 0 | -76.36M | |
|---|---|---|---|
| 2015 | 0 | -97.59M | |
| 2016 | 1.27M | -173.14M | -13537.37% |
| 2017 | 30.76M | -197.48M | -641.87% |
| 2018 | 77.47M | -178.84M | -230.84% |
| 2019 | 145.96M | -204.74M | -140.27% |
| 2020 | 88.63M | -224.43M | -253.2% |
| 2021 | 86.34M | -217.66M | -252.08% |
| 2022 | 107.67M | -134.51M | -124.93% |
| 2023 | 127.04M | -110.55M | -87.02% |
HRTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 127.04M | 107.67M | 86.34M | 88.63M | 145.96M | 77.47M | 30.76M | 1.27M | 0 | 0 |
Cost of revenue | 65.10M | 54.87M | 46.02M | 36.18M | 61.61M | 27.51M | 4.58M | 35K | 734K | 54.83M |
Gross profit | 61.93M | 52.79M | 40.32M | 52.44M | 84.34M | 49.96M | 26.17M | 1.24M | -734K | -54.83M |
Operating exp. | ||||||||||
Research and development | 55.89M | 107.50M | 130.82M | 174.53M | 167.38M | 140.03M | 138.58M | 103.12M | 61.18M | 54.83M |
Selling and marketing | 67.64M | 82.51M | 87.17M | 63.85M | 89.76M | 64.60M | 56.60M | 47.66M | 17.34M | 8.70M |
Total operating expenses | 172.55M | 227.45M | 258.15M | 280.61M | 295.04M | 233.89M | 220.73M | 172.15M | 96.92M | 74.56M |
Operating income | -110.61M | -174.65M | -217.82M | -228.16M | -210.69M | -183.93M | -194.55M | -170.91M | -96.92M | -74.56M |
Other income (expenses), net | 56K | -7.36M | -2.85M | 885K | 5.94M | 5.09M | -2.92M | -2.22M | -666K | -1.80M |
Income before tax | -110.55M | -182.02M | -220.68M | -227.27M | -204.74M | -178.84M | -197.48M | -173.14M | -97.59M | -76.36M |
Income tax expense | 0 | -47.50M | -3.02M | -2.84M | 0 | 7.76M | 3.89M | -1.09M | -734K | -578K |
Net income | -110.55M | -134.51M | -217.66M | -224.43M | -204.74M | -178.84M | -197.48M | -173.14M | -97.59M | -76.36M |
Earnings per share | ||||||||||
Basic EPS | -0.8 | -1.24 | -2.21 | -2.47 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 |
Diluted EPS | -0.8 | -1.24 | -2.21 | -2.47 | -2.5 | -2.44 | -3.65 | -4.57 | -2.95 | -2.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |